READYCELL KITS APPLICATIONS
In Vitro Cytotoxicity Assays
Identifying potential toxicity at early research stages allows to optimize new compounds development.
ReadyCell CYTOTOXICITY ASSAY KITS
Advancing cell toxicity evaluation with ready-to-use cell-based plates.
CacoReady 96 Transwell
Measure and stratify the cellular toxicity of your new molecular entity by evaluating TEER resistance and LY Paracellular Flux.
CacoReady 96 Multiwell
A simple colorimetric method to screen compound cytotoxicity.
Say goodbye to outdated colorimetric assays!
Our new application notes on CacoReady plates will show you how to accurately predict and stratify intestinal compound toxicity evaluating the TEER value and the LY paracellular flux, two relevant indicators of the cell barrier integrity.
Get for free the latest protocol for acute toxicity assessment.
CELL TOXICITY ASSAY
Ensure the safety of your new molecule
Drug-induced gastrointestinal reactions are one of the main causes of post-market drug withdrawal. These adverse effects can potentially be predicted by in vitro assays, since these side effects, like diarrhea, correlate with intestinal barrier dysfunction. In this regard, the most commonly used models for intestinal drug studies in pharmaceutical research consist of human intestinal epithelial cells, such as the colon adenocarcinoma cell line Caco-2.
There is a growing interest in using in vitro cytotoxicity tests instead of in vivo test systems to assess the cell viability of new molecular entities. This approach offers several advantages like reducing the need for animal testing, lowering costs, and speeding up the development and availability of these molecules. Although we should be cautious when comparing results from in vitro and in vivo tests due to their complexity, it is often observed that short-term cytotoxicity tests show positive responses that align well with short-term in vivo implantation tests.
CYTOTOXICITY ASSAY PROTOCOL
Cell toxicity testing and stratification in transwell plates
READYCELL Support
Frequently Asked Questions
What are the differences between transwell, no-transwell and individual transwell?
Caco-2 cells seeded on transwell inserts allow them to differentiate and polarise with an apical and basal surface which is mandatory to establish their barrier function. The Transwell system let using cell barrier disruption as an indicator of compounds’ toxicity. Transwells can be either integrated or singles, the latter recommended for assays requiring individual mobility at different time periods or measurements.
The non-Transwell format contains differentiated but not polarised Caco-2 cells. Late-stage indicators through colourimetric tests are used to measure the adverse effects of tested compounds.
For an effective cytotoxicity assay protocol, as well as a permeability assay protocol, it’s crucial to consider the choice of well system carefully.
What do the current regulations establish on the basis of cell toxicity tests?
Which are the main reference compounds for CacoReady and what are the differences between them?
Is it possible to add a testing service to the order?
Which reagents are suitable for cell viability assays using non-transwell plates?
Is the quality control data specific for each kit?
Does ReadyCell shipping medium affect cell lines?
No, ReadyCell’s Shipping Medium consists of a semi-solid culture system specifically designed to preserve cells at room temperature (15-25ºC). This medium maintains a suitable physicochemical environment, keeping adequate moisture conditions for cellular homeostasis and forming a protective cushion that protects cell integrity and functionality during long-distance shipments up to seven days.
Related news
Select the right well system for your research: A comprehensive guide.
In preclinical research, the choice of the appropriate well system format – whether it’s a transwell, non-transwell, or individual transwell – can significantly impact the outcome of experiments. Selecting the correct plate is crucial to working with permeability, toxicity, drug screening, or other assays.
A new study that uses CacoReady reveals a potent inhibitor for prostate cancer
Evaluating in vitro permeability with CacoReady plates was central to the study design. By quantifying the permeability of the synthesized compounds within Caco-2 cells, researchers could identify and select which compounds were best in terms of cellular adsorption.
Presenting the last advances in transporters in Germany
On May 15-17, the 22nd Barrier- and Transporter- days took place in Germany. At the event, Jonatan Cucala, R&D researcher at ReadyCell, presented a poster entitled “PreadyTake, an in vitro ready-to-use cell-based model to evaluate potential drug-transporter interactions.”
